ATAI Life Sciences Announces Joint Venture with DemeRx to Develop Ibogaine for Opioid Use Disorder. Read more at www.ATAI.life
Learn more about our management team, board of directors, and scientific advisors who are leading the effort to tackle opioid addiction. Read more.
Our natural product lead drug – lbogaine – is an indole alkaloid from equatorial Africa, which blocks opioid withdrawal symptoms and drug cravings, helping drug dependent patients to transition to sobriety. The Company has developed a robust IP portfolio around Noribogaine, the principal active metabolite of lbogaine.